References

1. Padhani AR, Dixon AK. Whole body computed tomography: recent developments. In: Grainger RG, Allison D (eds). Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging, vol 1. New York: Churchill Livingstone, 2001:81-82.

2. Okuda T, Korogi Y, Shigematsu Y, et al. Brain lesions: when should fluid-attenuated inversion-recovery sequences be used in MR evaluation? Radiology 1999;212(3):793-798.

3. Pomper MG, Port JD. New techniques in MR imaging of brain tumors. Magn Reson Imaging Clin N Am 2000;8(4):691-713.

4. Maubon AJ, Pothin A, Ferru JM, Berger VM, Daures JP, Rouanet JP. Unselected brain 0.5-T MR imaging: comparison of lesion detection and characterization with three T2-weighted sequences. Radiology 1998;208(3):671-678.

5. De Coene B, Hajnal JV, Gatehouse P, et al. MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. AJNR Am J Neuroradiol 1992;13(6):1555-1564.

6. Tsuchiya K, Mizutani Y, Hachiya J. Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors. AJNR Am J Neuroradiol 1996;17(6):1081-1086.

7. Bynevelt M, Britton J, Seymour H, MacSweeney E, Thomas N, Sandhu K. FLAIR imaging in the follow-up of low-grade gliomas: time to dispense with the dual-echo? Neuroradiology 2001; 43(2):129-133.

8. Chen S, Ikawa F, Kurisu K, Arita K, Takaba J, Kanou Y. Quantitative MR evaluation of intracranial epidermoid tumors by fast fluid-attenuated inversion recovery imaging and echo-planar diffusion-weighted imaging. AJNR Am J Neuroradiol 2001;22(6): 1089-1096.

9. Ikushima I, Korogi Y, Hirai T, et al. MR of epidermoids with a variety of pulse sequences. AJNR Am J Neuroradiol 1997;18(7): 1359-1363.

10. Singh SK, Agris JM, Leeds NE, Ginsberg LE. Intracranial lep-tomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imaging. Radiology 2000;217(1):50-53.

11. Griffiths PD, Coley SC, Romanowski CA, Hodgson T, Wilkinson ID. Contrast-enhanced fluid-attenuated inversion recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol 2003;24(4):719-723.

12. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging. 1996;14(9):1113-1116.

13. Dorenbeck U, Butz B, Schlaier J, Bretschneider T, Schuierer G, Feuerbach S. Diffusion-weighted echo-planar MRI of the brain with calculated ADCs: a useful tool in the differential diagnosis of tumor necrosis from abscess? J Neuroimaging 2003;13(4): 330-338.

14. Guzman R, Barth A, Lovblad KO, et al. Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain processes from cystic brain tumors. J Neurosurg 2002; 97(5):1101-1107.

15. Chang SC, Lai PH, Chen WL, et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: com parison with conventional MRI. Clin Imaging 2002;26(4):227-236.

16. Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002;23(8): 1369-1377.

17. Kim YJ, Chang KH, Song IC, et al. Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging. AJR Am J Roentgenol 1998; 171(6):1487-1490.

18. Chan JH, Tsui EY, Chau LF, et al. Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 2002;26(1): 19-23.

19. Nadal Desbarats L, Herlidou S, de Marco G, et al. Differential MRI diagnosis between brain abscesses and necrotic or cystic brain tumors using the apparent diffusion coefficient and normalized diffusion-weighted images. Magn Reson Imaging 2003; 21(6):645-650.

20. Tsuruda JS, Chew WM, Moseley ME, Norman D. Diffusion-weighted MR imaging of the brain: value of differentiating between extraaxial cysts and epidermoid tumors. AJNR Am J Neuroradiol 1990;11(5):925-931; discussion 932-924.

21. Tsuruda JS, Chew WM, Moseley ME, Norman D. Diffusion-weighted MR imaging of extraaxial tumors. Magn Reson Med 1991;19(2):316-320.

22. Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9(1):53-60.

23. Kotsenas AL, Roth TC, Manness WK, Faerber EN. Abnormal diffusion-weighted MRI in medulloblastoma: does it reflect small cell histology? Pediatr Radiol 1999;29(7):524-526.

24. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003;24(2):225-233.

25. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001;22(6):1081-1088.

26. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44(8):656-666.

27. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001;22(1):60-64.

28. Stadnik TW, Chaskis C, Michotte A, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuro-radiol 2001;22(5):969-976.

29. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191(1):41-51.

30. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171(6):1479-1486.

31. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24(10):1989-1998.

32. Yang S, Wetzel S, Law M, Zagzag D, Cha S. Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR Am J Neuroradiol 2002;23(3):350-355.

33. Shin JH, Lee HK, Kwun BD, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002; 179(3):783-789.

34. Lam WW, Chan KW, Wong WL, Poon WS, Metreweli C. Preoperative grading of intracranial glioma. Acta Radiol 2001;42(6): 548-554.

35. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfu-sion-weighted magnetic resonance imaging. Neurosci Lett 2003; 338(2):119-122.

36. Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology 1998;208(3):663-669.

37. Grand S, Passaro G, Ziegler A, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spec-troscopy: initial results. Radiology 1999;213(3):785-793.

38. Burtscher IM, Holtas S. Proton magnetic resonance spectroscopy in brain tumours: clinical applications. Neuroradiology 2001; 43(5):345-352.

39. Fulham MJ, Bizzi A, Dietz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185(3):675-686.

40. Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50(3):215-226.

41. Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non-neoplastic brain lesions. AJNR Am J Neuroradiol 1997;18(9): 1695-1704.

42. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninva-sive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2(3):323-325.

43. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44(5):371-381.

44. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22(4):604-612.

45. Martin AJ, Liu H, Hall WA, Truwit CL. Preliminary assessment of turbo spectroscopic imaging for targeting in brain biopsy. AJNR Am J Neuroradiol 2001;22(5):959-968.

46. Croteau D, Scarpace L, Hearshen D, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 2001; 49(4):823-829.

47. Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004;59(1):77-85.

48. Matthews PM, Jezzard P. Functional magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2004;75(1):6-12.

49. Fandino J, Kollias SS, Wieser HG, Valavanis A, Yonekawa Y. Intraoperative validation of functional magnetic resonance imaging and cortical reorganization patterns in patients with brain tumors involving the primary motor cortex. J Neurosurg 1999;91(2):238-250.

50. Lurito JT, Lowe MJ, Sartorius C, Mathews VP. Comparison of fMRI and intraoperative direct cortical stimulation in localization of receptive language areas. J Comput Assist Tomogr 2000; 24(1):99-105.

51. Paulesu E, Connelly A, Frith CD, et al. Functional MR imaging correlations with positron emission tomography. Initial experience using a cognitive activation paradigm on verbal working memory. Neuroimaging Clin N Am 1995;5(2):207-225.

52. Krings T, Schreckenberger M, Rohde V, et al. Functional MR] and 18F FDG-positron emission tomography for presurgical planning: comparison with electrical cortical stimulation. Acta Neurochir (Wien) 2002;144(9):889-899; discussion 899.

53. Schreiber A, Hubbe U, Ziyeh S, Hennig J. The influence of gliomas and nonglial space-occupying lesions on blood-oxygen-level-dependent contrast enhancement. AJNR Am J Neuroradiol 2000;21(6):1055-1063.

54. Holodny AI, Schulder M, Liu WC, Wolko J, Maldjian JA, Kalnin AJ. The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. AJNR Am J Neuroradiol 2000;21(8):1415-1422.

55. Gauvain KM, McKinstry RC, Mukherjee P, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177(2):449-454.

56. Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astro-cytic tumors. J Neurooncol 2003;63(2):109-116.

57. Mori S, Frederiksen K, van Zijl PC, et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002;51(3):377-380.

58. Sinha S, Bastin ME, Whittle IR, Wardlaw JM. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuro-radiol 2002;23(4):520-527.

59. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24(5):937-941.

60. Yamada K, Kizu O, Mori S, et al. Brain fiber tracking with clinically feasible diffusion-tensor MR imaging: initial experience. Radiology 2003;227(1):295-301.

61. Chao ST, Suh JH, Raja S, Lee SY, Barnett G. The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radio-surgery. Int J Cancer 2001;96(3):191-197.

62. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19(3):407-413.

63. De Witte O, Levivier M, Violon P, et al. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-d-glucose in the low-grade glioma. Neurosurgery 1996;39(3):470-476; discussion 476-477.

64. Barker FG JR, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer (Phila)1997;79(1): 115-126.

65. Spence AM, Mankoff DA, Muzi M. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2003; 13(4):717-739.

66. Sun D, Liu Q, Liu W, Hu W. Clinical application of 201Tl SPECT imaging of brain tumors. J Nucl Med 2000;41(1):5-10.

67. Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993;34(12):2085-2089.

68. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003;33(2):148-162.

69. Golfinos JG, Fitzpatrick BC, Smith LR, Spetzler RF. Clinical use of a frameless stereotactic arm: results of 325 cases. J Neurosurg 1995;83(2):197-205.

70. Wirtz CR, Albert FK, Schwaderer M, et al. The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res 2000;22(4):354-360.

71. Gildenberg PL, Woo SY. Multimodality program involving stereotactic surgery in brain tumor management. Stereotact Funct Neurosurg 2000;75(2-3):147-152.

72. Knauth M, Wirtz CR, Tronnier VM, Aras N, Kunze S, Sartor K. Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. AJNR Am J Neurora-diol 1999;20(9):1642-1646.

73. Tuominen J, Yrjana SK, Katisko JP, Heikkila J, Koivukangas J. Intraoperative imaging in a comprehensive neuronavigation environment for minimally invasive brain tumour surgery. Acta Neurochir Suppl 2003;85:115-120.

74. Kanner AA, Vogelbaum MA, Mayberg MR, Weisenberger JP, Barnett GH. Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience. J Neurosurg 2002;97(5):1115-1124.

75. Wirtz CR, Knauth M, Staubert A, et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 2000;46(5):1112-1120; discussion 1120-1121.

76. Lewin JS, Metzger A, Selman WR. Intraoperative magnetic resonance image guidance in neurosurgery. J Magn Reson Imaging 2000;12(4):512-524.

77. Thompson TP, Lunsford LD, Kondziolka D. Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy. Stereotact Funct Neuro-surg 1999;73(1-4):9-14.

78. Kahn D, Follett KA, Bushnell DL, et al. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs. 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994;163(6):1459-1465.

79. Schlemmer HP, Bachert P, Herfarth KK, Zuna I, Debus J, van Kaick G. Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. AJNR Am J Neuro-radiol 2001;22(7):1316-1324.

80. Rock JP, Hearshen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathol-ogy, with special attention to radiation necrosis. Neurosurgery 2002;51(4):912-919; discussion 919-920.

81. Siegal T, Rubinstein R, Tzuk-Shina T, Gomori JM. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow-up of brain tumors. J Neurosurg 1997;86(1):22-27.

82. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21(5):901-909.

83. Bitzer M, Klose U, Nagele T, et al. Echo planar perfusion imaging with high spatial and temporal resolution: methodology and clinical aspects. Eur Radiol 1999;9(2):221-229.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment